| Pharmaceutical Information |
| Drug Name |
Gadofosveset trisodium |
| Drug ID |
BADD_D00988 |
| Description |
Gadofosveset trisodium is an intravenous contrast agent used with magnetic resonance angiography(MRA), which is a non-invasive way of imaging blood vessels. The agent allows for the vascular system to be imaged more clearly by the MRA. In this way, gadofosveset trisodium is used to help diagnose certain disorders of the heart and blood vessels. |
| Indications and Usage |
Gadofosveset trisodium is indicated for use as a contrast agent in magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease. |
| Marketing Status |
approved |
| ATC Code |
V08CA11 |
| DrugBank ID |
DB06705
|
| KEGG ID |
D04286
|
| MeSH ID |
C109932
|
| PubChem ID |
73049652
|
| TTD Drug ID |
D0H0WK
|
| NDC Product Code |
Not Available |
| UNII |
XM33Q67UVH
|
| Synonyms |
gadofosveset trisodium | gadofosveset | MS 325 | MS-325 | Vasovist |
|
| Chemical Information |
| Molecular Formula |
C33H38GdN3Na3O14P |
| CAS Registry Number |
193901-90-5 |
| SMILES |
C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC
(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.[Na+].[Na+].[Na+].[Gd+3] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
